Cerebral Vasoreactivity Assessed With Transcranial Doppler and Regional Cerebral Blood Flow Measurements
- 1 December 1995
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 26 (12) , 2302-2306
- https://doi.org/10.1161/01.str.26.12.2302
Abstract
Background and Purpose To improve the assessment of cerebral vasoreactivity using acetazolamide (ACZ), we studied the time course of the response and the relationship between dose, response, and serum concentration. Methods Blood flow velocities were measured with the use of transcranial Doppler ultrasonography in one of the middle cerebral arteries of 48 healthy subjects after the intravenous administration of 1 to 1.6 g ACZ. In 34 subjects (group 1), velocities were measured every second minute to detect the maximum middle cerebral artery velocity increase. We also measured regional cerebral blood flow using single-photon emission computed tomography in 27 of the subjects in group 1 before and approximately 15 to 20 minutes after the ACZ injection. The serum concentration of ACZ was measured in 15 subjects. In the remaining 14 subjects (group 2), middle cerebral artery velocity measurements were made 10, 25, 30, and 45 minutes after ACZ administration to obtain information regarding the late time course of the response. Results In group 1 the plateau phase of the velocity response was reached 8 to 15 minutes after ACZ administration. A large range of velocity increase was observed, and a significant correlation was found between the maximum velocity increase and the dose and serum concentration of ACZ. In group 2 subjects, maximum velocities were maintained 30 minutes after the injection, but after 45 minutes velocities had decreased to 68% of their highest level. No significant relationship was found between dose or serum concentration of ACZ and the regional cerebral blood flow increase. The velocity increase after ACZ was similar in both older and younger subjects. Conclusions This study shows that cerebral vasoreactivity is best assessed 10 to 30 minutes after ACZ administration and that the dose should probably exceed 15 mg/kg if a maximum vasodilatory response in the cerebral circulation is to be obtained.Keywords
This publication has 22 references indexed in Scilit:
- Simultaneous Assessment of Vasoreactivity Using Transcranial Doppler Ultrasound and Cerebral Blood Flow in Healthy SubjectsJournal of Cerebral Blood Flow & Metabolism, 1994
- Indomethacin Abolishes Cerebral Blood Flow Increase in Response to Acetazolamide-Induced Extracellular Acidosis: A Mechanism for its Effect on Hypercapnia?Journal of Cerebral Blood Flow & Metabolism, 1993
- Is central chemoreceptor sensitive to intracellular rather than extracellular pH?Clinical Physiology and Functional Imaging, 1990
- Cluster Headache: Transcranial Doppler Ultrasound and rCBF StudiesCephalalgia, 1990
- Neuronal pH Regulation: Constant Normal Intracellular pH is Maintained in Brain during Low Extracellular pH Induced by Acetazolamide—31P NMR StudyJournal of Cerebral Blood Flow & Metabolism, 1989
- The rCBF response to Diamox in normal subjects and cerebrovascular disease patientsJournal of Neurosurgery, 1987
- Histochemical study of the distribution of carbonic anhydrase in the cat brainActa Physiologica Scandinavica, 1985
- Carbon dioxide permeability of the blood-brain barrier in manMicrovascular Research, 1980
- Nonlinear Model for AcetazolamideJournal of Pharmaceutical Sciences, 1979
- Brain Carbonic Acid Acidosis after AcetazolamideActa Physiologica Scandinavica, 1975